BRIM Biotechnology Inc (全福生技) is today to debut its shares on the Emerging Stock Board at an initial offering price of NT$35 per share, the company told an investors’ conference yesterday.
The Taipei Exchange’s Emerging Stock Board is a preparatory board for the nation’s two main bourses.
The company would use the funds raised on the market to conduct phase 3 clinical trials of the BRM421 drug for dry eye disease next year and in 2024, if its meeting with the US Food and Drug Administration upon the conclusion of phase 2 trials goes smoothly this year, it said.
Photo courtesy of BRIM Biotechnology Inc
The company aims to expedite human trials by one year if it has sufficient funds, it said.
Previous human trials for BRM421 showed the drug could stimulate self-renewal of gimbal stem cells and conjunctival goblet cells. That could speed up corneal regeneration and improve the quality of tear, the company said.
“Dry eye disease is a common chronic disease, but has complicated causes,” BRIM chairwoman Jang Hai-shan (簡海珊) said.
“There is no effective treatment yet. More than half of the medicines [for dry eye disease] are anti-inflammatory prescription drugs, with the remaining being artificial tears,” she said.
BRIM is optimistic that BRM421 could be approved as a first-line treatment for dry eye disease, because it is innovative and utilizes a peptide-based regeneration medicine that advances the renewal of stem cells, Jang said.
While it takes about three months for those who use Novartis AG’s dry eye treatment Xiidra to experience relief, it takes about two weeks for those who use BRM421, the company said, adding that its drug has milder side effects, as it is based on a natural short-chain peptide.
Its drug should have an advantage over other treatments in the European market, the company said.
BRIM forecasts a compound annual growth rate of 10.6 percent in the number of patients with dry eye disease from 2018 to 2027, and predicts that the number of patients would grow to 11 billion in 2027, from 5.22 billion in 2020, because people use more electronic devices, wear contact lens more often and have more laser eye surgeries, it said.
FALLING BEHIND: Samsung shares have declined more than 20 percent this year, as the world’s largest chipmaker struggles in key markets and plays catch-up to rival SK Hynix Samsung Electronics Co is laying off workers in Southeast Asia, Australia and New Zealand as part of a plan to reduce its global headcount by thousands of jobs, sources familiar with the situation said. The layoffs could affect about 10 percent of its workforces in those markets, although the numbers for each subsidiary might vary, said one of the sources, who asked not to be named because the matter is private. Job cuts are planned for other overseas subsidiaries and could reach 10 percent in certain markets, the source said. The South Korean company has about 147,000 in staff overseas, more than half
Taipei is today suspending its US$2.5 trillion stock market as Super Typhoon Krathon approaches Taiwan with strong winds and heavy rain. The nation is not conducting securities, currency or fixed-income trading, statements from its stock and currency exchanges said. Yesterday, schools and offices were closed in several cities and counties in southern and eastern Taiwan, including in the key industrial port city of Kaohsiung. Taiwan, which started canceling flights, ship sailings and some train services earlier this week, has wind and rain advisories in place for much of the island. It regularly experiences typhoons, and in July shut offices and schools as
An Indian factory producing iPhone components resumed work yesterday after a fire that halted production — the third blaze to disrupt Apple Inc’s local supply chain since the start of last year. Local industrial behemoth Tata Group’s plant in Tamil Nadu, which was shut down by the unexplained fire on Saturday, is a key linchpin of Apple’s nascent supply chain in the country. A spokesperson for subsidiary Tata Electronics Pvt yesterday said that the company would restart work in “many areas of the facility today.” “We’ve been working diligently since Saturday to support our team and to identify the cause of the fire,”
TECH PARTNERSHIP: The deal with Arizona-based Amkor would provide TSMC with advanced packing and test capacities, a requirement to serve US customers Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is collaborating with Amkor Technology Inc to provide local advanced packaging and test capacities in Arizona to address customer requirements for geographical flexibility in chip manufacturing. As part of the agreement, TSMC, the world’s biggest contract chipmaker, would contract turnkey advanced packaging and test services from Amkor at their planned facility in Peoria, Arizona, a joint statement released yesterday said. TSMC would leverage these services to support its customers, particularly those using TSMC’s advanced wafer fabrication facilities in Phoenix, Arizona, it said. The companies would jointly define the specific packaging technologies, such as TSMC’s Integrated
RSS